Interventional Cardiology News and Research

RSS

Positive outcomes from Medtronic's Resolute drug-eluting stent against coronary artery disease

Results of two major clinical studies presented at ACC.11 - the 60th Annual Scientific Session & Expo of the American College of Cardiology - demonstrate that the Resolute drug-eluting stent from Medtronic, Inc., provides a positive and persistent treatment effect for a wide variety of patients with coronary artery disease.

5 Apr 2011

Positive results from Abbott's ABSORB device trial in coronary artery disease

Abbott today announced positive one-year results from 101 patients enrolled in the second phase of the ABSORB trial evaluating the world's first drug eluting Bioresorbable Vascular Scaffold for the treatment of coronary artery disease.

4 Apr 2011

PLC's RenalGuard System REMEDIAL II trial final results to be presented at ACC conference

PLC Systems Inc., a company focused on innovative medical device technologies, today reported that final results from the REMEDIAL II investigator-sponsored clinical trial of its RenalGuard System™ in Italy are scheduled to be presented at 11:57 a.m. CT on Monday, April 4, 2011, at the American College of Cardiology's 60th Annual Scientific Session & Expo in New Orleans, Louisiana. Additionally, PLC will be demonstrating RenalGuard at its booth at the conference.

2 Apr 2011

Abbott launches MitraClip system to treat MR in Australia

Abbott today announced the launch of the company's catheter-based MitraClip system for the treatment of mitral regurgitation in Australia. The MitraClip device, which has received Therapeutic Goods Administration approval, offers a new treatment option for patients suffering from MR, a debilitating heart valve condition.

31 Mar 2011

Medtronic's Resolute drug-eluting stent pivotal U.S. data to be presented at ACC.11

Medtronic, Inc., today announced the imminent release of the pivotal U.S. data on its Resolute drug-eluting stent at ACC.11, the 60th Annual Scientific Session & Expo of the American College of Cardiology, which takes place April 2-5 in New Orleans.

29 Mar 2011

ACE supports HHS' National Strategy for Quality Improvement in Health Care

The Accreditation for Cardiovascular Excellence, a nonprofit organization whose mission is to ensure high-quality patient care and promote patient safety in facilities where invasive cardiac and endovascular procedures are performed, supports the National Strategy for Quality Improvement in Health Care issued today by the U.S. Department of Health and Human Services.

22 Mar 2011

Corindus begins CorPath Percutaneous Robotic-Enhanced Coronary Intervention Study trial

Corindus Vascular Robotics, a leading developer of precision vascular robotics, announced today that the clinical trial of its CorPath PRECISE has begun.

16 Mar 2011

OrbusNeich launches CE marked Azule Cobalt Chromium Stent

OrbusNeich today announced the launch of the CE marked Azule Cobalt Chromium Stent. The Azule Stent combines the proven stent design of its predecessor, the company's Blazer™ Cobalt Chromium Stent, with a delivery system with enhanced crossability and flexible deliverability.

14 Mar 2011

Cedars-Sinai earns excellence in 2010 adult heart transplants

The Cedars-Sinai Heart Institute and Comprehensive Transplant Center performed the most adult heart transplants of any U.S. medical center in 2010, according to government statistics released today.

10 Mar 2011

SCAI statement highlights multiple recommendations for evaluating PCI quality at cardiac facilities

Today the Society for Cardiovascular Angiography and Interventions announced the publication of recommendations for assessing and improving program quality at percutaneous coronary intervention programs at cardiac facilities.

2 Mar 2011

New CPR method improves long-term survival rates in patients with cardiac arrest by 50%

A five-year clinical trial led by University of Minnesota Medical School researchers has led to a new method of cardiopulmonary resuscitation that improves long-term survival rates with good brain function by 50 percent.

1 Mar 2011

$MHI begins patient enrollment for new device to treat refractory angina$

MHI begins patient enrollment for new device to treat refractory angina

The interventional cardiology team at the Montreal Heart Institute recently began patient enrolment for a new device, the Neovasc Reducer, designed to treat patients suffering from refractory angina.

25 Feb 2011

Opsens completes pre-clinical EasyWire device study for measurement of FFR in coronary arteries

Opsens Inc. said today that its Medical Division has reached a significant milestone, successfully completing a pre-clinical animal study on the EasyWire device, designed to measure Fractional Flow Reserve in the evaluation of coronary lesions.

24 Feb 2011

InfraReDx to showcase LipiScan IVUS Coronary Imaging System at CRT 2011

InfraReDx, Inc., a medical device company providing intelligent cardiovascular diagnostic imaging technologies, today announced that its LipiScan™ IVUS Coronary Imaging System will be featured in several presentations during the annual Cardiovascular Research Technologies (CRT) 2011 meeting, being held February 27 through March 1, 2011 at the Omni Shoreham Hotel in Washington, D.C.

24 Feb 2011

Xenogenics retains Emmes to assist with development, execution of its capital formation strategy

Xenogenics Corporation, a majority owned subsidiary of MultiCell Technologies, Inc., is pleased to announce it has retained the Emmes Group to assist with the development and execution of its capital formation strategy to help finance expanded human clinical trials of its Ideal BioStent.

24 Feb 2011

Study: Drug-eluting stents outperform BMS for revascularization of CTOs

A systematic review of medical evidence has determined drug-eluting stents outperform bare metal stents for revascularization of chronic total occlusions.

10 Feb 2011

Cardiac team implants pulmonary valve in children without open-heart surgery

The pediatric cardiac team at Oregon Health & Science University Doernbecher Children's Hospital is the first in the region and one of a handful in the nation to implant a pulmonary heart valve without open-heart surgery.

4 Feb 2011

Innovative Heart Attack Rapid Response Team for snow shoveling heart attacks

Loyola's innovative Heart Attack Rapid Response Team (HARRT) is on staff 24/7 to perform emergency surgery on patients who have experienced heart attacks from shoveling snow or other causes.

3 Feb 2011

Boston Scientific announces merger agreement to acquire Atritech

Boston Scientific Corporation today announced the signing of a definitive merger agreement, under which the Company will acquire Atritech, a privately held company based in Plymouth, Minnesota.

19 Jan 2011

World's first drug eluting bioresorbable vascular scaffold receives CE Mark approval

Abbott announced today that it has received CE Mark approval for the world's first drug eluting bioresorbable vascular scaffold (BVS) for the treatment of coronary artery disease. Abbott's BVS device restores blood flow by opening a clogged vessel and providing support to the vessel until the device dissolves within approximately two years, leaving patients with a treated vessel free of a permanent metallic implant. Abbott's BVS device will be commercialized under the brand name ABSORB.

10 Jan 2011

Interventional Cardiology News and Research

Positive outcomes from Medtronic's Resolute drug-eluting stent against coronary artery disease

Positive results from Abbott's ABSORB device trial in coronary artery disease

PLC's RenalGuard System REMEDIAL II trial final results to be presented at ACC conference

Abbott launches MitraClip system to treat MR in Australia

Medtronic's Resolute drug-eluting stent pivotal U.S. data to be presented at ACC.11

ACE supports HHS' National Strategy for Quality Improvement in Health Care

Corindus begins CorPath Percutaneous Robotic-Enhanced Coronary Intervention Study trial

OrbusNeich launches CE marked Azule Cobalt Chromium Stent

Cedars-Sinai earns excellence in 2010 adult heart transplants

SCAI statement highlights multiple recommendations for evaluating PCI quality at cardiac facilities

New CPR method improves long-term survival rates in patients with cardiac arrest by 50%

MHI begins patient enrollment for new device to treat refractory angina

Opsens completes pre-clinical EasyWire device study for measurement of FFR in coronary arteries

InfraReDx to showcase LipiScan IVUS Coronary Imaging System at CRT 2011

Xenogenics retains Emmes to assist with development, execution of its capital formation strategy

Study: Drug-eluting stents outperform BMS for revascularization of CTOs

Cardiac team implants pulmonary valve in children without open-heart surgery

Innovative Heart Attack Rapid Response Team for snow shoveling heart attacks

Boston Scientific announces merger agreement to acquire Atritech

World's first drug eluting bioresorbable vascular scaffold receives CE Mark approval

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News